Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
Xia Wu, Heather Landau, Jennifer E. Liu, Yihan Cao, Raymond L. Comenzo · 2026
Read Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates by Xia Wu, Heather Landau, Jennifer E. Liu, Yihan Cao, Raymond L. Comenzo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13245762.txt.
Description
Xia Wu and co-authors (2026) review systemic light-chain amyloidosis, a rare disease in which a plasma cell clone spills misfolded protein chains that deposit in organs. Diagnosis is often late because early signs are vague and workup spans several specialties. The review covers the biology, the diagnostic path, and how treatment has changed since a landmark trial of an antibody-based regimen.
That regimen reshaped first-line care. Better genetic profiling of the clone, finer measures of leftover disease, and refined transplant strategies now support risk-adapted management. Newer options include a BCL-2 targeted drug, bispecific antibodies, engineered T cell therapy, and possibly treatments aimed at the deposits themselves. The authors close on the remaining challenge: turning organ damage back and keeping patients alive longer, not just clearing the clone.
Catalog record
| CREATOR | Xia Wu, Heather Landau, Jennifer E. Liu, Yihan Cao, Raymond L. Comenzo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |